Market Research Logo

Thalassaemia Pipeline Highlights – 2017 Update

Thalassaemia Pipeline Highlights – 2017 Update

The latest report from Fore Pharma, Thalassaemia Pipeline Highlights – 2017 Update, provides most up-to-date information on key pipeline products in the global Thalassaemia market. It covers emerging therapies for Thalassaemia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Thalassaemia pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Thalassaemia pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Thalassaemia pipeline products by the company.

Short-term Launch Highlights:
Find out which Thalassaemia pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:

  • Thalassaemia phase 3 clinical trial pipeline products
  • Thalassaemia phase 2 clinical trial pipeline products
  • Thalassaemia phase 1 clinical trial pipeline products
  • Thalassaemia preclinical research pipeline products
  • Thalassaemia discovery stage pipeline products
  • Thalassaemia pipeline products short-term launch highlights


1. Thalassaemia Pipeline by Stages
2. Thalassaemia Pipeline by Drug Class
3. Thalassaemia Pipeline by Company
4. Thalassaemia Phase 3 Clinical Trial Insights
5. Thalassaemia Phase 2 Clinical Trial Insights
6. Thalassaemia Phase 1 Clinical Trial Insights
7. Thalassaemia Preclinical Research Insights
8. Thalassaemia Discovery Stage Insights
9. Appendix
10. Research Methodology
LIST OF TABLES
Table 1: Thalassaemia Phase 3 Clinical Trials, 2017
Table 2: Thalassaemia Phase 2 Clinical Trials, 2017
Table 3: Thalassaemia Phase 1 Clinical Trials, 2017
Table 4: Thalassaemia Preclinical Research, 2017
Table 5: Thalassaemia Discovery Stage, 2017
LIST OF FIGURES
Figure 1: Thalassaemia Pipeline Molecules by Clinical Trials Stage, 2017
Figure 2: Thalassaemia Pipeline Molecules by Drug Class, 2017
Figure 3: Thalassaemia Pipeline Molecules by Company, 2017
Figure 4: Thalassaemia Phase 3 Clinical Trial Highlights, 2017
Figure 5: Thalassaemia Phase 2 Clinical Trial Highlights, 2017
Figure 6: Thalassaemia Phase 1 Clinical Trial Highlights, 2017
Figure 7: Thalassaemia Preclinical Research Highlights, 2017
Figure 8: Thalassaemia Discovery Stage Highlights, 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report